N Adib1, A Silman, W Thomson. 1. Arthritis Research Campaign Epidemiology Unit, School of Epidemiology and Health Sciences, University of Manchester Medical School, Manchester M13 9PT, UK.
Abstract
OBJECTIVE: To assess the relative contributions of demographic, clinical and laboratory variables in predicting outcome in juvenile idiopathic inflammatory arthritis (JIA), based on a review of the existing literature. METHODS: Electronic reference database searches for the previous 10 yr were conducted and studies examining the role of major potential predictors of main outcomes were identified. Where possible, subjects were grouped by JIA disease subtype. In addition to demographic variables, the following disease-related predictors were assessed: nature of joint involvement, acute-phase response, and presence of autoantibodies. These were then analysed for three main outcomes of interest: remission as assessed by disease activity; functional impairment; and structural damage as assessed by radiological joint erosions. RESULTS: In general, female gender, polyarticular and symmetrical joint involvement, elevated inflammatory markers and rheumatoid factor positivity were the most consistent predictors of a poor outcome, although the studies were frequently inconsistent in both the direction and the magnitude of the effects. CONCLUSIONS: These data are too variable to accurately identify those predictors associated with poor outcome following the onset of JIA. Although some of this variation may be the result of true differences between study populations, the vast majority of inconsistencies are explainable by the absence of standardized classification systems, outcome definitions, therapeutic approach and research tools. More comprehensive prospective evaluation is required before robust prediction models can be generated.
OBJECTIVE: To assess the relative contributions of demographic, clinical and laboratory variables in predicting outcome in juvenile idiopathic inflammatory arthritis (JIA), based on a review of the existing literature. METHODS: Electronic reference database searches for the previous 10 yr were conducted and studies examining the role of major potential predictors of main outcomes were identified. Where possible, subjects were grouped by JIA disease subtype. In addition to demographic variables, the following disease-related predictors were assessed: nature of joint involvement, acute-phase response, and presence of autoantibodies. These were then analysed for three main outcomes of interest: remission as assessed by disease activity; functional impairment; and structural damage as assessed by radiological joint erosions. RESULTS: In general, female gender, polyarticular and symmetrical joint involvement, elevated inflammatory markers and rheumatoid factor positivity were the most consistent predictors of a poor outcome, although the studies were frequently inconsistent in both the direction and the magnitude of the effects. CONCLUSIONS: These data are too variable to accurately identify those predictors associated with poor outcome following the onset of JIA. Although some of this variation may be the result of true differences between study populations, the vast majority of inconsistencies are explainable by the absence of standardized classification systems, outcome definitions, therapeutic approach and research tools. More comprehensive prospective evaluation is required before robust prediction models can be generated.
Authors: Simon W M Eng; Florence A Aeschlimann; Mira van Veenendaal; Roberta A Berard; Alan M Rosenberg; Quaid Morris; Rae S M Yeung Journal: PLoS Med Date: 2019-02-26 Impact factor: 11.069
Authors: P C E Hissink Muller; W G van Braak; D Schreurs; C M Nusman; S A Bergstra; R Hemke; D Schonenberg-Meinema; J M van den Berg; T W Kuijpers; Y Koopman-Keemink; M A J van Rossum; L W A van Suijlekom-Smit; D M C Brinkman; C F Allaart; R Ten Cate; M Maas Journal: Pediatr Rheumatol Online J Date: 2019-09-04 Impact factor: 3.054
Authors: Ana Filipa Mourão; Maria José Santos; Sílvia Mendonça; Filipa Oliveira-Ramos; Manuel Salgado; Paula Estanqueiro; José Melo-Gomes; Fernando Martins; Ana Lopes; Bruno Filipe Bettencourt; Jácome Bruges-Armas; José Costa; Carolina Furtado; Ricardo Figueira; Iva Brito; Jaime Branco; João Eurico Fonseca; Helena Canhão Journal: J Immunol Res Date: 2015-10-04 Impact factor: 4.818
Authors: Veronika Rypdal; Ellen Dalen Arnstad; Kristiina Aalto; Lillemor Berntson; Maria Ekelund; Anders Fasth; Mia Glerup; Troels Herlin; Susan Nielsen; Suvi Peltoniemi; Marek Zak; Marite Rygg; Martin Rypdal; Ellen Nordal Journal: Arthritis Res Ther Date: 2018-05-03 Impact factor: 5.156